Atrium Therapeutics, Inc. (RNA) Price History & Returns
How Atrium Therapeutics, Inc. (RNA) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.
The share price of $8.20 sits 8% of the way up a 52-week range of $7.49 to $16.77; 51.1% below the 52-week high; below its 50-day moving average of $10.26; below its 200-day average of $12.19; a beta of 0.37 means it has historically moved less than the market.
Total return
Price change over each trailing period, not annualised.
Monthly closing prices
The last 9 months, newest first. 3 of 8 months closed higher than the month before. Each figure is the last close in that month.
Atrium Therapeutics, Inc. (RNA) price history — frequently asked questions
How has Atrium Therapeutics, Inc. performed over the last year?
Atrium Therapeutics, Inc. (RNA) has risen 0.0% over the last twelve months, measured on price alone.
What is Atrium Therapeutics, Inc.'s five-year return?
Over five years the RNA share price has gained 0.0%, excluding dividends.
What is Atrium Therapeutics, Inc.'s 52-week range?
Over the last year Atrium Therapeutics, Inc. (RNA) has traded between $7.49 and $16.77.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.